Jennifer S. Haas, MD, MSPH
Articles
November 16th 2012
Active Pharmacovigilance and Healthcare Utilization
Jennifer S. Haas, MD, MSPH Elissa Klinger, SM Lucas Xavier Marinacci, BA Phyllis Brawarsky, MPH E. John Orav, PhD Gordon D. Schiff, MD David W. Bates, MD, MSc
This study highlights the potential value of innovative ways of collecting information about adverse drug events directly from patients.
May 15th 2011
Genomic Testing and Therapies for Breast Cancer in Clinical Practice
Jennifer S. Haas, MD, MSPH Kathryn A. Phillips, PhD Su-Ying Liang, PhD Michael J. Hassett, MD, MPH Carol Keohane, BSN, RN Elena B. Elkin, PhD Joanne Armstrong, MD, MPH Michele Toscano, MS
Despite almost universal testing for human-epidermal-growth-factor-receptor-2 (HER2), many women with a HER2-positive cancer may not receive trastuzumab. Fewer women received the newer gene-expression-profile (GEP) test.
Latest Updated Articles
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: December 12th 2013 | Updated: October 23rd 2024
Relying on ACOs and TCOC Contracting to 'Bend the Cost Curve'
Published: March 18th 2014 | Updated: October 23rd 2024
It's Time to Embolden the Nation's Experiments With ACOs
Published: July 16th 2013 | Updated: October 23rd 2024
Healthcare's 'Big Data' Challenge
Published: July 10th 2013 | Updated: October 23rd 2024
Early Results From the Hospital Electronic Health Record Incentive Programs
